The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246–Val4271 Reveals a Fifth Calcium Binding Site
The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246–Val4271 Reveals a Fifth Calcium Binding Site
Calmodulin (CaM) regulates the activity of a Ca2+ channel known as the cardiac ryanodine receptor (RyR2), which facilitates the release of Ca2+ from the sarcoplasmic reticulum during excitation-contraction coupling in cardiomyocytes. Mutations that disrupt this CaM-dependent channel inactivation result in cardiac arrhythmias. RyR2 contains three different CaM binding sites: CaMBD1 (residues 1940-1965), CaMBD2 (residues 3580-3611), and CaMBD3 (residues 4246-4275). Here, we report a crystal structure of Ca2+-bound CaM bound to RyR2 CaMBD3. The structure reveals Ca2+ bound to the four EF-hands of CaM as well as a fifth Ca2+ bound to CaM in the interdomain linker region involving Asp81 and Glu85. The CaM mutant E85A abolishes the binding of the fifth Ca2+ and weakens the binding of CaMBD3 to Ca2+-bound CaM. Thus, the binding of the fifth Ca2+ is important for stabilizing the complex in solution and is not a crystalline artifact. The CaMBD3 peptide in the complex adopts an α-helix (between Phe4246 and Val4271) that interacts with both lobes of CaM. Hydrophobic residues in the CaMBD3 helix (Leu4255 and Leu4259) form intermolecular contacts with the CaM N-lobe, and the CaMBD3 mutations (L4255A and L4259A) each weaken the binding of CaM to RyR2. Aromatic residues on the opposite side of the CaMBD3 helix (Phe4246 and Tyr4250) interact with the CaM C-lobe, but the mutants (F4246A and Y4250A) have no detectable effect on CaM binding in solution. We suggest that the binding of CaM to CaMBD3 and the binding of a fifth Ca2+ to CaM may contribute to the regulation of RyR2 channel function.
- University of California, San Francisco United States
- University of California System United States
- University of California, Davis United States
- University of California, San Diego / Department of Chemistry & Biochemistry United States
570, Biochemistry & Molecular Biology, Phenylalanine, Medical Physiology, 610, Medical Biochemistry and Metabolomics, Cardiovascular, Medicinal and Biomolecular Chemistry, Calmodulin, Medicinal and biomolecular chemistry, Medical biochemistry and metabolomics, Humans, Binding Sites, Biomedical and Clinical Sciences, Cryoelectron Microscopy, Ryanodine Receptor Calcium Release Channel, Valine, Heart Disease, Biochemistry and cell biology, Mutation, Calcium, Biochemistry and Cell Biology, Crystallization, Protein Binding
570, Biochemistry & Molecular Biology, Phenylalanine, Medical Physiology, 610, Medical Biochemistry and Metabolomics, Cardiovascular, Medicinal and Biomolecular Chemistry, Calmodulin, Medicinal and biomolecular chemistry, Medical biochemistry and metabolomics, Humans, Binding Sites, Biomedical and Clinical Sciences, Cryoelectron Microscopy, Ryanodine Receptor Calcium Release Channel, Valine, Heart Disease, Biochemistry and cell biology, Mutation, Calcium, Biochemistry and Cell Biology, Crystallization, Protein Binding
4 Research products, page 1 of 1
- 2020IsSupplementTo
- 2020IsRelatedTo
- 2019IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).8 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
